5/6腎摘ラットにおけるL-ArginineのNO産生および糸球体組織に対する逆説的用量依存性効果

Saved in:
Bibliographic Details
Published in日本腎臓学会誌 Vol. 41; no. 8; pp. 754 - 763
Main Authors 中西, 健, 井上, 徹, 蓮池, 由起子, 野口, 光一, 高光, 義博, 田中, 俊彦
Format Journal Article
LanguageJapanese
Published 社団法人 日本腎臓学会 1999
Online AccessGet full text
ISSN0385-2385
1884-0728
DOI10.14842/jpnjnephrol1959.41.754

Cover

Author 高光, 義博
中西, 健
蓮池, 由起子
野口, 光一
田中, 俊彦
井上, 徹
Author_xml – sequence: 1
  fullname: 中西, 健
  organization: 兵庫医科大学腎透析学
– sequence: 1
  fullname: 井上, 徹
  organization: 兵庫医科大学腎透析学
– sequence: 1
  fullname: 蓮池, 由起子
  organization: 兵庫医科大学腎透析学
– sequence: 1
  fullname: 野口, 光一
  organization: 兵庫医科大学腎透析学
– sequence: 1
  fullname: 高光, 義博
  organization: 兵庫医科大学腎透析学
– sequence: 1
  fullname: 田中, 俊彦
  organization: 兵庫医科大学腎透析学
BookMark eNpdkLlOw0AYhFcIJELgGXgCB_-76-y6RIhLRKSB2vKxBlvBRA4UdBhzKUgcwgUgjoKCGwqERAryMpvE4S0wAlHQzBTzzRQzgHqD5UAgNAxqASineMSvBn4gqovhcgV0TS9QKDCN9qAccE4VlWHei3Iq4ZqCM-lHQ7WaZ6nAmUo0RnNoVRspdrf2O0cnMr6TcSzjXRk9yKguoyO5sVdSRsMFL_ACIaPn2XKaXKfJ1Xe6kWGv6et7ehi3Po7Tt820kWTF9ktTRqdZ8XN9u3v_mJ5tpsnt585Bq3nRfjrprN-0643O5fkg6nPNSk0M_XoezU-Mz41NKaXy5PTYaEnxgVBT0YBRnQjL0THGqusCMC6wzS3NsR0HE0fFjLtABAirSMAuQoZpxOImWBwzIHk087Pr11bMBWFUQ2_JDNcMM1zx7Iow_r1nUDD4j2Qn_lH2ohkavkm-AFonk64
ContentType Journal Article
Copyright 社団法人日本腎臓学会
Copyright_xml – notice: 社団法人日本腎臓学会
DOI 10.14842/jpnjnephrol1959.41.754
DeliveryMethod fulltext_linktorsrc
EISSN 1884-0728
EndPage 763
ExternalDocumentID article_jpnjnephrol1959_41_8_41_8_754_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
OK1
RJT
ID FETCH-LOGICAL-j134a-517493ebd92220ff1178e2c8b5dcdd23d0278f13e1eb631c6122053b8a1b82713
ISSN 0385-2385
IngestDate Wed Sep 03 06:06:12 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 8
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j134a-517493ebd92220ff1178e2c8b5dcdd23d0278f13e1eb631c6122053b8a1b82713
OpenAccessLink https://www.jstage.jst.go.jp/article/jpnjnephrol1959/41/8/41_8_754/_article/-char/ja
PageCount 10
ParticipantIDs jstage_primary_article_jpnjnephrol1959_41_8_41_8_754_article_char_ja
PublicationCentury 1900
PublicationDate 1999
PublicationDateYYYYMMDD 1999-01-01
PublicationDate_xml – year: 1999
  text: 1999
PublicationDecade 1990
PublicationTitle 日本腎臓学会誌
PublicationTitleAlternate 日腎会誌
PublicationYear 1999
Publisher 社団法人 日本腎臓学会
Publisher_xml – name: 社団法人 日本腎臓学会
References 4. Ashab I, Peer G, Blum M, Wollman Y, Chernihovsky T, Hassner A, Schwartz D, Cabili S, Silverberg D, Iaina A. Oral administration of L-Arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int 1995; 47:1515-21.
5. Katoh T, Takahashi K, Klahr S, Alvalo AR Badr KF. Dietary supplementation with L-Arginine ameliorates glomerular hypertention in rats with subtotal nephrectomy. J Am Soc Nephrol 1994; 4:1690-4.
9. Vallance P, Leone A, Calver A, Collier J, Monkada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-5.
18. Remuzzi P, Puntorieri S, Alfano M, Macconi D, Abbate M, Bertani T, Remuzzi G. Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury. Lab Invest 1992; 67 : 572-9.
16. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertention and glomerular damage. J Clin Invest 1992; 90: 278-81.
3. Nishihara F. Renal protective effects of nitric oxide in 5/6 nephrectomized rats attenuation of glomerular sclerosis by the β-blocker with an ONO2 group. Acta Med Hyogo 1996; 21: 71-85.
22. Garg UC, Hassid A. Inhibition of rat mesangial cell mitogenesis by nitric oxide generating vasodilators. Am J Physiol 1989; 257: F60-6.
23. Radomski MW, Palmer RMJ, Monkada S. The anti-aggregating propertie of vascular endothelium interactions between prostacyclin and nitric oxide. Br J Phamacol 1987; 92: 639-46.
12. Fuhr J, Kaczmarczyk J. Eine einfache Colorimetrsche Methode zur Inulinbestim-mung fur Nieren-Clearance-Untersuchungen bei Stoffwechselgesunden and Diabetikern. Klin Wochenschr 1995; 33: 729-30.
26. Tojyo A, Gross SS, Zhang GL, Tisher CC, Schmidt H, Wilcox S, Madsen KM. Immunocytochemical Localization of Distinct Isoforms of Nitric Oxide Synthase in the Juxtaglomerular Apparatus of Normal Rat Kidney. J Am Soc Nephrol 1994; 4:1438-47.
25. Benigni A, Zoja C, Coma D. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 1993; 44: 440-4.
13. Raji L, Azar S, Keane W. Mesangial immune injury, hypertension and progressive glomerular damage in Dahl rats. Kidney Int 1984; 26 :137-43.
7. Narita I, Border WA, Ketteler MK, Ruoslahti ER, Noble NA. L-arginine may mediate the therapeutic effects of low protein diets. Proc Natl Acad Sci USA 1995; 92: 4552-6.
11. Patchett ML, Monk CR, Daniel RM, Morgan HW. Determination of agmatine, arginine, citrulline and ornithine by reversed-phase liquid chromatography using automated pre-column derivatization with ophthalaldehyde. J Chromatogr 1988; 425: 269-76.
8. Anderson S, Helmut GR, Barry MB. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77 :1993-2000.
14. Reyes AA, Purkerson L, Karl I, Klahr S. Dietary supplementation with L-Arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis 1992; 26:137-43.
17. Palmer RMJ, Ashton S, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-9.
15. Alvaro A, Karl IE, Klahr S. Role of arginine in health and in renal disease. Am Physiol Soc 1994 : F331-42.
21. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert A, Bowen-Pope DF, Couser WG, Johnson R. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992; 41: 297-309.
27. Todoroki S, Goto S, Urata Y, Komatsu K, Sumikawa K, Ogura T, Matsuda I, Kondo T. High concentration of L-arginine suppresses nitric oxide synthase activity and produces reactive oxygen species in NB9 human neuroblastoma cells. Mol Med 1998; 4: 515-24.
6. Alvaro AR, Irene E, Karl JK, Klahr S. L-Arginine Administration Prevents Glomerular Hyperfiltration and Decrease Proteinuria in Diabetic Rats. J Am Soc Nephrol 1993; 4: 1039-45.
28. Peters H, Noble NA. Angiotensin II and L-arginine in tissue fibrosis: more than blood pressure. Int Soc Nephrol 1997; 4:1481-6.
20. Fries JWU, Sandstrom DJ, Meyer TW, Rennke HG. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest 1989; 60: 205-18.
2. Fujihara CK, Nucci GD, Zatz R. Chronic Nitric Oxide Synthase Inhibition Aggravates Glomerular Injury in Rats with Subtotal Nephrectomy. J Am Soc Nephrol 1995; 5: 1498-507.
10. Li X, Yuasa H, Hitomi H, Hashimoto M, Fujioka H, Kiyomoto K, Uchida K, Shoji S, Takahashi N, Matsuo U, Miyatake A. Mechanism mediating hypertension induced by chronic inhition of nitric oxide synthesis. Jap J Nephrol 1997; 39: 718-27.
19. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertention limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76: 612-9.
1. Simons JL, Provoost AP, Anderson S, Rennke HG, Troy JL. Moduration of glomerular hypertention defines susceptibility to progressive glomerular injury. Kidney Int 1994; 46: 396-404.
24. Sigmon DH, Carretero OA, Beierwaltes WH, William O. Endothelium-derived relaxing factor regulates renin release in vivo. Am J Physiol 1992; F256-61.
References_xml – reference: 21. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert A, Bowen-Pope DF, Couser WG, Johnson R. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992; 41: 297-309.
– reference: 18. Remuzzi P, Puntorieri S, Alfano M, Macconi D, Abbate M, Bertani T, Remuzzi G. Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury. Lab Invest 1992; 67 : 572-9.
– reference: 20. Fries JWU, Sandstrom DJ, Meyer TW, Rennke HG. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest 1989; 60: 205-18.
– reference: 8. Anderson S, Helmut GR, Barry MB. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77 :1993-2000.
– reference: 9. Vallance P, Leone A, Calver A, Collier J, Monkada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-5.
– reference: 24. Sigmon DH, Carretero OA, Beierwaltes WH, William O. Endothelium-derived relaxing factor regulates renin release in vivo. Am J Physiol 1992; F256-61.
– reference: 4. Ashab I, Peer G, Blum M, Wollman Y, Chernihovsky T, Hassner A, Schwartz D, Cabili S, Silverberg D, Iaina A. Oral administration of L-Arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int 1995; 47:1515-21.
– reference: 17. Palmer RMJ, Ashton S, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-9.
– reference: 16. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertention and glomerular damage. J Clin Invest 1992; 90: 278-81.
– reference: 2. Fujihara CK, Nucci GD, Zatz R. Chronic Nitric Oxide Synthase Inhibition Aggravates Glomerular Injury in Rats with Subtotal Nephrectomy. J Am Soc Nephrol 1995; 5: 1498-507.
– reference: 15. Alvaro A, Karl IE, Klahr S. Role of arginine in health and in renal disease. Am Physiol Soc 1994 : F331-42.
– reference: 11. Patchett ML, Monk CR, Daniel RM, Morgan HW. Determination of agmatine, arginine, citrulline and ornithine by reversed-phase liquid chromatography using automated pre-column derivatization with ophthalaldehyde. J Chromatogr 1988; 425: 269-76.
– reference: 3. Nishihara F. Renal protective effects of nitric oxide in 5/6 nephrectomized rats attenuation of glomerular sclerosis by the β-blocker with an ONO2 group. Acta Med Hyogo 1996; 21: 71-85.
– reference: 12. Fuhr J, Kaczmarczyk J. Eine einfache Colorimetrsche Methode zur Inulinbestim-mung fur Nieren-Clearance-Untersuchungen bei Stoffwechselgesunden and Diabetikern. Klin Wochenschr 1995; 33: 729-30.
– reference: 22. Garg UC, Hassid A. Inhibition of rat mesangial cell mitogenesis by nitric oxide generating vasodilators. Am J Physiol 1989; 257: F60-6.
– reference: 1. Simons JL, Provoost AP, Anderson S, Rennke HG, Troy JL. Moduration of glomerular hypertention defines susceptibility to progressive glomerular injury. Kidney Int 1994; 46: 396-404.
– reference: 13. Raji L, Azar S, Keane W. Mesangial immune injury, hypertension and progressive glomerular damage in Dahl rats. Kidney Int 1984; 26 :137-43.
– reference: 26. Tojyo A, Gross SS, Zhang GL, Tisher CC, Schmidt H, Wilcox S, Madsen KM. Immunocytochemical Localization of Distinct Isoforms of Nitric Oxide Synthase in the Juxtaglomerular Apparatus of Normal Rat Kidney. J Am Soc Nephrol 1994; 4:1438-47.
– reference: 6. Alvaro AR, Irene E, Karl JK, Klahr S. L-Arginine Administration Prevents Glomerular Hyperfiltration and Decrease Proteinuria in Diabetic Rats. J Am Soc Nephrol 1993; 4: 1039-45.
– reference: 27. Todoroki S, Goto S, Urata Y, Komatsu K, Sumikawa K, Ogura T, Matsuda I, Kondo T. High concentration of L-arginine suppresses nitric oxide synthase activity and produces reactive oxygen species in NB9 human neuroblastoma cells. Mol Med 1998; 4: 515-24.
– reference: 10. Li X, Yuasa H, Hitomi H, Hashimoto M, Fujioka H, Kiyomoto K, Uchida K, Shoji S, Takahashi N, Matsuo U, Miyatake A. Mechanism mediating hypertension induced by chronic inhition of nitric oxide synthesis. Jap J Nephrol 1997; 39: 718-27.
– reference: 5. Katoh T, Takahashi K, Klahr S, Alvalo AR Badr KF. Dietary supplementation with L-Arginine ameliorates glomerular hypertention in rats with subtotal nephrectomy. J Am Soc Nephrol 1994; 4:1690-4.
– reference: 28. Peters H, Noble NA. Angiotensin II and L-arginine in tissue fibrosis: more than blood pressure. Int Soc Nephrol 1997; 4:1481-6.
– reference: 14. Reyes AA, Purkerson L, Karl I, Klahr S. Dietary supplementation with L-Arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis 1992; 26:137-43.
– reference: 23. Radomski MW, Palmer RMJ, Monkada S. The anti-aggregating propertie of vascular endothelium interactions between prostacyclin and nitric oxide. Br J Phamacol 1987; 92: 639-46.
– reference: 25. Benigni A, Zoja C, Coma D. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 1993; 44: 440-4.
– reference: 7. Narita I, Border WA, Ketteler MK, Ruoslahti ER, Noble NA. L-arginine may mediate the therapeutic effects of low protein diets. Proc Natl Acad Sci USA 1995; 92: 4552-6.
– reference: 19. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertention limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76: 612-9.
SSID ssib018703574
ssib004261733
ssib058493074
ssib000833381
ssib002004354
ssib005879731
ssib039893136
ssib008531636
ssib038076193
ssj0000696431
ssib000940323
ssib002822005
ssib038586121
ssib047305546
Score 1.5009327
SourceID jstage
SourceType Publisher
StartPage 754
Title 5/6腎摘ラットにおけるL-ArginineのNO産生および糸球体組織に対する逆説的用量依存性効果
URI https://www.jstage.jst.go.jp/article/jpnjnephrol1959/41/8/41_8_754/_article/-char/ja
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本腎臓学会誌, 1999, Vol.41(8), pp.754-763
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR25btRA1IpCQ4NAgLiVgqmQg8ce2zPleNcrzqQJUhq0Wh-LtEIBRUlDlWW5FCQOkSIgjoKCG4oICQr4GZMY_oL3xuMjQAERkmU9e97l92zPe_bMG8M46kW2iDlNzSQRzGSCxSbvR7HZc6yExj48UAwnCp-d8k6cY6dm3dmx8fONUUuLC9FkfOWP80q24lU4B37FWbL_4NmKKZwAGPwLe_Aw7P_Kx1iwwSMhJ9wlPCShRwQlgpPQIRz_f2sANg0UTZTIQANcagAIEbAJD86Ycv4CrhuRltjh1DQJfSIYkY4GRGczB7tmHigc2AdcIVtKAUaCNhFFE2jLFCCQVa2SS2SHBGGpkqhUIqHAIRlcXayURLYUZ6n5oGJc4fiEd5SskIi2YthWBvGQXPp4BhQGuWgrwGk1g3N10ifSVUBLSalsy5E56q94Sk9JaaEOhUq8-tysWjhiYYtLgg7ex0o0XKa7CU0S4Wp80EujgfKBqNE4ipXKvQEwsAo0ddVwDM1gz8AvL9aqCQt7hEpyB11XqgGbKKVa9XcfrBVRPaMoQSpDAoUIlOc99KpWGKwoj23NYo3Ox-GuCeFcYZS06Bw5Z6bl68n8uvcsypbptwRvdIV-URxcR1W6G_utw2acYQXgweW5wVwKr69LF7Ha0SSjkxX9pmro-lnr_kLQZbTLix3QdUssnLnYHUD6tM32fYojftsnTzezD8dpTkMXzHKa2QD-Jm9WG4Rg-pfFHajfyJZc7uNCcNUxRMKQ7VTRPoWu0XHrbAuXevBo3T3iL3qs51cdC8glaE3PfKzOV3-9gdRBOGUpqyLwxOJ6ao3Q0nt6RCta-fifbQyR9wDy0HIMqwqrZ3YaO3Q-PCELU-4yxga93caie9z7fv3Oxv3VbPQqG42y0a1s-CYbLmfD-9nV2_ULKhu-n5rOV57nK8-w9SqgreVrn_J7o29fHuQfr-WfV4Bw_cPXbPgQCH8s3fj--m3-6Fq-8vLHzbvfvj5Zf7e6sfRiffnzxtPHe4xznXCmdcLU68OYA-qwnolF9oWTRomAJMfq9yn1eWrHPHKTOElsJ8FRFX3qpDSNPIfGYFwbYo6I92jEbZ86e43xuUtz6T5jQqTC7cU0cfqRxzwOSVTas9046UOM76eRvd9oF1bqXi6KAHW3dCMe-D9sDhrbi-ox-CX4kDG-ML-YHobcaCE6ou7wn8SNJEc
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=5%2F6%E8%85%8E%E6%91%98%E3%83%A9%E3%83%83%E3%83%88%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8BL-Arginine%E3%81%AENO%E7%94%A3%E7%94%9F%E3%81%8A%E3%82%88%E3%81%B3%E7%B3%B8%E7%90%83%E4%BD%93%E7%B5%84%E7%B9%94%E3%81%AB%E5%AF%BE%E3%81%99%E3%82%8B%E9%80%86%E8%AA%AC%E7%9A%84%E7%94%A8%E9%87%8F%E4%BE%9D%E5%AD%98%E6%80%A7%E5%8A%B9%E6%9E%9C&rft.jtitle=%E6%97%A5%E6%9C%AC%E8%85%8E%E8%87%93%E5%AD%A6%E4%BC%9A%E8%AA%8C&rft.au=%E4%B8%AD%E8%A5%BF%2C+%E5%81%A5&rft.au=%E4%BA%95%E4%B8%8A%2C+%E5%BE%B9&rft.au=%E8%93%AE%E6%B1%A0%2C+%E7%94%B1%E8%B5%B7%E5%AD%90&rft.au=%E9%87%8E%E5%8F%A3%2C+%E5%85%89%E4%B8%80&rft.date=1999&rft.pub=%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E8%85%8E%E8%87%93%E5%AD%A6%E4%BC%9A&rft.issn=0385-2385&rft.eissn=1884-0728&rft.volume=41&rft.issue=8&rft.spage=754&rft.epage=763&rft_id=info:doi/10.14842%2Fjpnjnephrol1959.41.754&rft.externalDocID=article_jpnjnephrol1959_41_8_41_8_754_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0385-2385&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0385-2385&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0385-2385&client=summon